(Q45048847)

English

High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial

scientific article published on 7 September 2004

Statements

High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial (English)
Elizabeth R Miller
William J Sasiela
Gregory G Schwartz
Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit